Condition
Stroke Prevention in Patients With Atrial Fibrillation
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Not Yet Recruiting2
Terminated1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07349121Not ApplicableNot Yet Recruiting
OPTION-EMEA Clinical Trial
NCT07575867Recruiting
CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention
NCT07257614Not Yet Recruiting
Left Atrial Appendage Occlusion in Dialysis Patients With Atrial Fibrillation: A Multicentre Pilot Study
NCT00206063Phase 2TerminatedPrimary
Long Term Open Follow-up With H376/95 vs. Warfarin
Showing all 4 trials